02625nam 2200697z- 450 991055742230332120210501(CKB)5400000000043471(oapen)https://directory.doabooks.org/handle/20.500.12854/69411(oapen)doab69411(EXLCZ)99540000000004347120202105d2020 |y 0engurmn|---annantxtrdacontentcrdamediacrrdacarrierActinobacteria and MyxobacteriaImportant Resources for Novel AntibioticsBasel, SwitzerlandMDPI - Multidisciplinary Digital Publishing Institute20201 online resource (270 p.)3-03943-529-9 3-03943-530-2 Bacterial infections cause millions of deaths globally, particularly in children and the elderly, and four of the 10 leading causes of death are infectious diseases in low- and middle-income countries. The continuous use of antibiotics has resulted in multi-resistant bacterial strains all over the world, such as Community-associated Methicillin-resistant Staphylococcus aureus (MRSA), extended-spectrum β-lactamases (ESBLs), and, as expected, hospitals have become breeding grounds for human-associated microorganisms, especially in critical care units.Actinobacteria and MyxobacteriaBiology, life sciencesbicsscResearch & information: generalbicsscactinomycetesantibiotic biosynthesisantimicrobialantioxidantantiviralscytotoxicitydiversityEbolaenzyme inhibitionGC-MShepatitis virusesHiTESHIVmarine actinobacteriamyxobacterianew antibioticspolyketide synthases (PKSs)polyketidespyrrolopyrazinessecondary metabolitesecondary metabolitessilent biosynthetic pathwaysStreptomycesStreptomyces sp.translation inhibitorsunculturedγ-butyrolactonesBiology, life sciencesResearch & information: generalWink Joachimedt1299261Wink JoachimothBOOK9910557422303321Actinobacteria and Myxobacteria3025090UNINA